Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2965 (LINC02965)

Target: LINC02965
Molecular classification: Other, Long non-coding RNA, lncRNA

Overview

Long intergenic non-protein coding RNA 2965 (LINC02965) is a human long non-coding RNA (lncRNA) gene located on chromosome 19 (region 19:34837889... by hg38 coordinates)[5][7]. As an lncRNA, LINC02965 does not encode a protein[3]. Its biological function remains unclear and is not well characterized in the current literature; it is currently annotated as a non-protein coding gene, and no direct links to specific diseases, therapeutic relevance, or biomarker uses have been established[1][3][5][11]. There are no known drugs or mechanisms of action targeting this RNA, and it is not currently considered a therapeutic target or a clinically actionable biomarker. The locus has a few alternative names, but all refer to the same lncRNA entity, and it is classified within the broader family of long intergenic non-coding RNAs[1][5][7][9].

Other names: CTC-523E23.5lnc-ZNF30-3

Biological functions

Othernon-coding RNApredicted roles in regulation rather than direct protein function

Disease associations

There is currently no direct evidence or consensus linking LINC02965 specifically to major disease roles (such as cancer, inflammation, neurodegeneration, or cardiovascular disease)[1][3][5][7][11].Some long intergenic non-coding RNAs are involved in cancer, but there is no published functional or disease role for this specific entry.

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2965 (LINC02965).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2965 (LINC02965).

Explore the full profile